Esculetin

Esculetin

SCHEMBL4065440

O=c1cc(C(F)(F)F)c2ccccc2o1.O=c1ccc2cc(O)c(O)cc2o1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 4/20 0.61
CA9 Q16790 5/20 0.60
CA12 O43570 4/20 0.60
KDM4E B2RXH2 3/20 0.60
ALDH1A1 P00352 3/20 0.60
GAA P10253 3/20 0.60
HPGD P15428 3/20 0.60
CASP1 P29466 3/20 0.60
CASP7 P55210 3/20 0.60
HSD17B10 Q99714 3/20 0.60
AKR1B1 P15121 3/20 0.60
CYP1A2 P05177 2/20 0.60
GLA P06280 2/20 0.60
HIF1A Q16665 2/20 0.60
ERAP1 Q9NZ08 2/20 0.60
LMNA P02545 1/20 0.60
BCHE P06276 1/20 0.60
CYP3A4 P08684 1/20 0.60
MAPT P10636 1/20 0.60
ALOX15 P16050 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30177134 0.84 ALDH1A1 (0.63) MCL1CA9CA12KDM4EALDH1A1
SCHEMBL698688 0.84 ALDH1A1 (0.63) MCL1CA9CA12KDM4EALDH1A1
SCHEMBL4620259 0.83 KDM4E (0.68) MCL1CA9CA12KDM4EALDH1A1
Ammonia Solution, Strong SCHEMBL599296 0.83 ALDH1A1 (0.61) MCL1CA9CA12KDM4EALDH1A1
Phosphoric Acid SCHEMBL3361101 0.80 HSD17B3 (0.59) MCL1CA9CA12KDM4EALDH1A1
Esculetin SCHEMBL8718947 0.78 CA9 (0.79) MCL1CA9CA12KDM4EALDH1A1
Esculetin SCHEMBL6867015 0.78 CA9 (1.00) MCL1CA9CA12KDM4EALDH1A1
Esculetin SCHEMBL24641 0.78 CA9 (1.00) MCL1CA9CA12KDM4EALDH1A1
Esculetin SCHEMBL29569228 0.78 CA9 (1.00) MCL1CA9CA12KDM4EALDH1A1
SCHEMBL592629 0.77 MCL1 (1.00) MCL1KDM4EALDH1A1GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049511-A1 USE OF COUMARIN DERIVATIVES IN ANTIFUNGAL THERAPY Novabiotics Limited (GB) 2009-04-22 EP disclosed
WO-2007141513-A1 USE OF COUMARIN DERIVATIVES IN ANTIFUNGAL THERAPY NOVABIOTICS LIMITED (GB) 2007-12-13 WO disclosed